Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
7(78%)
Results Posted
300%(3 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_1
1
11%
Ph phase_4
5
56%
Ph phase_3
1
11%
Ph phase_2
2
22%

Phase Distribution

1

Early Stage

2

Mid Stage

6

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
2(22.2%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
5(55.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

7

trials recruiting

Total Trials

9

all time

Status Distribution
Active(7)
Completed(1)
Terminated(1)

Detailed Status

Active, not recruiting6
Completed1
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
7
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 22 (22.2%)
Phase 31 (11.1%)
Phase 45 (55.6%)

Trials by Status

active_not_recruiting667%
completed111%
terminated111%
recruiting111%

Recent Activity

7 active trials
Showing 5 of 9
active_not_recruitingphase_2

Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

NCT03036930
active_not_recruitingphase_4

Establishing Optimal Number of Doses for HPV Vaccination in Children and Adolescents Living With HIV, OPTIMO Trial

NCT04265950
active_not_recruitingphase_4

Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial

NCT05237947
recruitingphase_1

Testing RG1-VLP Vaccine to Prevent HPV-related Cancers

NCT05985681
active_not_recruitingphase_2

Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants

NCT02568566
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT03036930Phase 2

Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

Active Not Recruiting
NCT04265950Phase 4

Establishing Optimal Number of Doses for HPV Vaccination in Children and Adolescents Living With HIV, OPTIMO Trial

Active Not Recruiting
NCT05237947Phase 4

Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial

Active Not Recruiting
NCT05985681Phase 1

Testing RG1-VLP Vaccine to Prevent HPV-related Cancers

Recruiting
NCT02568566Phase 2

Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants

Active Not Recruiting
NCT03284866Phase 3

HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPV

Completed
NCT03023631Phase 4

Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Active Not Recruiting
NCT03180034Phase 4

Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study

Active Not Recruiting
NCT03051516Phase 4

HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions

Terminated

All 9 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
9